EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure

Jitpisute Chunthorng-Orn iD, Maya Noureddine iD, Peter W J Dawson iD, Samuel O Lord iD, Jimi Ng, Luke Boyton, Katja Gehmlich iD, Fiyaz Mohammed iD, Yu-Chiang Lai iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jitpisute Chunthorng-Orn und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Tripartite Motif Proteins, Ubiquitination, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRC Versus Arthritis Centre for Musculoskeletal Aging Research, Medical Research Council, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MuRF1 [muscle RING (Really Interesting New Gene)-finger protein-1] is an ubiquitin-protein ligase (E3), which encode by TRIM63 (tripartite motif containing 63) gene, playing a crucial role in regulating cardiac muscle size and function through ubiquitylation. Among hypertrophic cardiomyopathy (HCM) patients, 24 TRIM63 variants have been identified, with 1 additional variant linked to restrictive cardiomyopathy. However, only three variants have been previously investigated for their functional effects. The structural impacts of the 25 variants remain unexplored. This study investigated the effects of 25 MuRF1 variants on ubiquitylation activity using in vitro ubiquitylation assays and structural predictions using computational approaches. The variants were generated using site-directed PCR (Polymerase Chain Reaction) mutagenesis and subsequently purified with amylose affinity chromatography. In vitro ubiquitylation assays demonstrated that all 25 variants compromised the ability of MuRF1 to monoubiquitylate a titin fragment (A168-A170), while 17 variants significantly impaired or completely abolished auto-monoubiquitylation. Structural modelling predicted that 10 MuRF1 variants disrupted zinc binding or key stabilising interactions, compromising structural integrity. In contrast, three variants were predicted to enhance the structural stability of MuRF1, while six others were predicted to have no discernible impact on the structure. This study underscores the importance of functional assays and structural predictions in evaluating MuRF1 variant pathogenicity and provides novel insights into mechanisms by which these variants contribute to HCM and related cardiomyopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesTripartite Motif ProteinsUbiquitinationCardiomyopathy, HypertrophicMuscle ProteinsHumansConnectinModels, MolecularProtein ConformationProtein BindingMutation

Stichwörter der Autor:innen

MuRF1MuRF1 domainsTRIM63hypertrophic cardiomyopathypathogenic variantsstructural modellingubiquitylation

Substanzen

Ubiquitin-Protein LigasesTripartite Motif ProteinsMuscle ProteinsTRIM63 protein, humanConnectin

Autor:innen und Institutionen

  • School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Department of Applied Thai Traditional Medicine, Faculty of Medicine, University of Thammasat, Pathumthani 12120, Thailand.
  • Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.
  • Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.
  • Centre for Systems Health and Integrated Metabolic Research, Department of Biosciences, Nottingham Trent University, Nottingham NG11 8NS, UK.
  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK.

ORCID-Profile: Jitpisute Chunthorng-Orn, Maya Noureddine, Peter W J Dawson, Samuel O Lord, Katja Gehmlich, Fiyaz Mohammed, Yu-Chiang Lai

Förderung

  • MRC Versus Arthritis Centre for Musculoskeletal Aging Research
  • Medical Research Council
  • British Heart Foundation
  • Ministry of Higher Education, Science, Research and Innovation, Thailand
  • Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Thailand

Zitieren

APA

Chunthorng-Orn, J., Noureddine, M., Dawson, P. W. J., Lord, S. O., Ng, J., Boyton, L., Gehmlich, K., Mohammed, F., & Lai, Y. C. (2025). HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083921

Vancouver

Chunthorng-Orn J, Noureddine M, Dawson PWJ, Lord SO, Ng J, Boyton L, et al. HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083921

BibTeX
@article{ChunthorngOrn2025,
  author = {Chunthorng-Orn, Jitpisute and Noureddine, Maya and Dawson, Peter W J and Lord, Samuel O and Ng, Jimi and Boyton, Luke and Gehmlich, Katja and Mohammed, Fiyaz and Lai, Yu-Chiang},
  title = {HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083921}
}
Kostenlos starten →